Tomas Milota

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Recurrence following invasive GAS infections in adults: Triumph of virulence or failure of immunity?

Recurrence following invasive GAS infections in adults: Triumph of virulence or failure of immunity?

Journal: Virulence
Published: September 29, 2025

First report from the Czech national registry of inborn errors of immunity (2012-2025).

First report from the Czech national registry of inborn errors of immunity (2012-2025).

Journal: Frontiers in immunology
Published: June 25, 2025

Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees.

Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: December 20, 2024

The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective.

The role of interleukin 6 in the pathogenesis and therapy of Castleman disease - an immunologist's perspective.

Journal: Casopis lekaru ceskych
Published: July 20, 2023

Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.

Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity.

Journal: The Journal of allergy and clinical immunology
Published: April 08, 2023

Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?

Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?

Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 06, 2023

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies.

Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies.

Journal: Pathogens (Basel, Switzerland)
Published: December 07, 2022

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients.

SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients.

Journal: Frontiers in immunology
Published: August 12, 2022

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs.

Immunogenicity and safety of the booster BNT162b2 vaccine in patients with axial spondyloarthritis treated with biological disease-modifying drugs.

Journal: Frontiers in immunology
Published: August 03, 2022

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis.

Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis.

Journal: Frontiers in immunology
Published: July 01, 2022

Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.

Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors.

Journal: Casopis lekaru ceskych
Published: March 31, 2022

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab.

Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab.

Journal: The Lancet. Rheumatology
Published: December 27, 2021
Showing 1-12 of 38

Last Updated: 09/26/2026